Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised…

By J. Mant, F. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, Gregory Y. H. Lip, E. Murray. The Lancet, 2007

1,597 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/c4b82efa537d09a3a20ac6b8bac8ac916da2dcea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerhard Hindricks
2. Gregory Y. H. Lip
3. A. Goette
4. Alan S. Go
5. Paulus Kirchhof
6. Ulrich Schotten

Citations in the corpus

• The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (2009, result): “These results are consistent with the recent BAFTA (Birmingham Atrial Fibrillation Treatment of the Aged Study) trial (18), in which patients with atrial fibrillation whose average age was 82 years benefited substantially from warfarin therapy.”